1,25-dihydroxyvitamin D3-mediated suppression of T lymphocyte functions and failure of T cell-activating cytokines to restore proliferation
- 30 September 1992
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 34 (1) , 37-44
- https://doi.org/10.1016/0165-2478(92)90025-j
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- 1,25-dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor bindingCellular Immunology, 1990
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- The immunobiology ofvitamin D: William F.C. RigbyImmunology Today, 1988
- Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunityImmunology Letters, 1988
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 productionCellular Immunology, 1986
- Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis.The Journal of Experimental Medicine, 1985
- Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).Journal of Clinical Investigation, 1984
- 1,25-Dihydroxyvitamin D 3 : a Novel Immunoregulatory HormoneScience, 1984
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983